Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 448

1.

Civic Engagement in California Cannabis Policy Development.

Bowling C, Glantz SA.

J Psychoactive Drugs. 2019 Jun 12. doi: 10.1080/02791072.2019.1627444. [Epub ahead of print]

PMID:
31187690
2.

Electronic Cigarette Use and Myocardial Infarction Among Adults in the US Population Assessment of Tobacco and Health.

Bhatta DN, Glantz SA.

J Am Heart Assoc. 2019 Jun 18;8(12):e012317. doi: 10.1161/JAHA.119.012317. Epub 2019 Jun 5.

3.

Tobacco industry promotions and pricing after tax increases: An analysis of internal industry documents.

Apollonio DE, Glantz SA.

Nicotine Tob Res. 2019 May 6. pii: ntz068. doi: 10.1093/ntr/ntz068. [Epub ahead of print]

PMID:
31058282
4.

Estimation of 1-Year Changes in Medicaid Expenditures Associated With Reducing Cigarette Smoking Prevalence by 1.

Glantz SA.

JAMA Netw Open. 2019 Apr 5;2(4):e192307. doi: 10.1001/jamanetworkopen.2019.2307.

5.

Exposure to household tobacco smoke and risk of cancer morbidity and mortality: Analysis of data from the Afghanistan Demographic and Health Survey 2015.

Bhatta DN, Hiatt RA, Van Loon K, Glantz SA.

Prev Med. 2019 Jun;123:217-224. doi: 10.1016/j.ypmed.2019.03.044. Epub 2019 Mar 30.

PMID:
30940572
6.

The Evidence of Electronic Cigarette Risks Is Catching Up With Public Perception.

Glantz SA.

JAMA Netw Open. 2019 Mar 1;2(3):e191032. doi: 10.1001/jamanetworkopen.2019.1032. No abstract available.

PMID:
30924882
7.

The Association Between E-cigarette Use and Myocardial Infarction Is What One Would Expect Based on the Biological and Clinical Evidence.

Alzahrani T, Glantz SA.

Am J Prev Med. 2019 Apr;56(4):627. doi: 10.1016/j.amepre.2018.11.006. No abstract available.

PMID:
30898224
8.

Tobacco industry involvement in children's sugary drinks market.

Nguyen KH, Glantz SA, Palmer CN, Schmidt LA.

BMJ. 2019 Mar 14;364:l736. doi: 10.1136/bmj.l736. No abstract available.

PMID:
30872273
9.

Corrigendum to "Similar softening across different racial and ethnic groups of smokers in California as smoking prevalence declined" [Prev. Med. 120 (2019) 144-149].

Kulik MC, Glantz SA.

Prev Med. 2019 Jun;123:343. doi: 10.1016/j.ypmed.2019.02.008. Epub 2019 Feb 15. No abstract available.

PMID:
30773313
10.

Estimating the long-run relationship between state cigarette taxes and county life expectancy.

Baum A, Aguilar-Gomez S, Lightwood J, Bruzelius E, Glantz SA, Basu S.

Tob Control. 2019 Jan 31. pii: tobaccocontrol-2018-054686. doi: 10.1136/tobaccocontrol-2018-054686. [Epub ahead of print]

PMID:
30705247
11.

Similar softening across different racial and ethnic groups of smokers in California as smoking prevalence declined.

Kulik MC, Glantz SA.

Prev Med. 2019 Mar;120:144-149. doi: 10.1016/j.ypmed.2019.01.020. Epub 2019 Jan 29. Erratum in: Prev Med. 2019 Feb 15;:.

PMID:
30703378
12.

Conflict of Interest Provisions in State Laws Governing Medical and Adult Use Cannabis.

Bowling CM, Glantz SA.

Am J Public Health. 2019 Mar;109(3):423-426. doi: 10.2105/AJPH.2018.304862. Epub 2019 Jan 24.

PMID:
30676801
13.

Memoranda of understanding: a tobacco industry strategy to undermine illicit tobacco trade policies.

Crosbie E, Bialous S, Glantz SA.

Tob Control. 2019 Jan 18. pii: tobaccocontrol-2018-054668. doi: 10.1136/tobaccocontrol-2018-054668. [Epub ahead of print]

PMID:
30659106
14.

E-cigarettes: Stick to the Evidence.

Alzahrani T, Pena I, Temesgen N, Glantz SA.

Am J Prev Med. 2019 Jan;56(1):160-161. doi: 10.1016/j.amepre.2018.09.004. No abstract available.

PMID:
30573144
15.

Scientific Quality of Health-Related Articles in Specialty Cannabis and General Newspapers in San Francisco.

Halvorson RT, Stewart CC, Thakur A, Glantz SA.

J Health Commun. 2018;23(12):993-998. doi: 10.1080/10810730.2018.1534906. Epub 2018 Oct 25.

PMID:
30358488
16.

Heated tobacco products: the example of IQOS.

Glantz SA.

Tob Control. 2018 Nov;27(Suppl 1):s1-s6. doi: 10.1136/tobaccocontrol-2018-054601. No abstract available.

17.

Heated tobacco product regulation under US law and the FCTC.

Lempert LK, Glantz SA.

Tob Control. 2018 Nov;27(Suppl 1):s118-s125. doi: 10.1136/tobaccocontrol-2018-054560. Epub 2018 Oct 5.

18.

Authors' Response.

van der Eijk Y, Bialous S, Glantz SA.

Pediatrics. 2018 Oct;142(4). pii: e20181783B. doi: 10.1542/peds.2018-1783B. No abstract available.

PMID:
30266871
19.

Light and mild redux: heated tobacco products' reduced exposure claims are likely to be misunderstood as reduced risk claims.

Popova L, Lempert LK, Glantz SA.

Tob Control. 2018 Nov;27(Suppl 1):s87-s95. doi: 10.1136/tobaccocontrol-2018-054324. Epub 2018 Sep 12.

20.

Heated tobacco products: another tobacco industry global strategy to slow progress in tobacco control.

Bialous SA, Glantz SA.

Tob Control. 2018 Nov;27(Suppl 1):s111-s117. doi: 10.1136/tobaccocontrol-2018-054340. Epub 2018 Sep 12.

21.

Association Between Electronic Cigarette Use and Myocardial Infarction.

Alzahrani T, Pena I, Temesgen N, Glantz SA.

Am J Prev Med. 2018 Oct;55(4):455-461. doi: 10.1016/j.amepre.2018.05.004. Epub 2018 Aug 22.

PMID:
30166079
22.

PMI's own in vivo clinical data on biomarkers of potential harm in Americans show that IQOS is not detectably different from conventional cigarettes.

Glantz SA.

Tob Control. 2018 Nov;27(Suppl 1):s9-s12. doi: 10.1136/tobaccocontrol-2018-054413. Epub 2018 Aug 21.

23.

Tobacco company strategies to identify and promote the benefits of nicotine.

Ling PM, Glantz SA.

Tob Control. 2019 May;28(3):289-296. doi: 10.1136/tobaccocontrol-2018-054300. Epub 2018 Aug 9.

PMID:
30093414
24.

Marketing with tobacco pack onserts: a qualitative analysis of tobacco industry documents.

Apollonio DE, Glantz SA.

Tob Control. 2019 May;28(3):274-281. doi: 10.1136/tobaccocontrol-2018-054279. Epub 2018 Jun 28.

25.

Marijuana Regulatory Frameworks in Four US States: An Analysis Against a Public Health Standard.

Barry RA, Glantz SA.

Am J Public Health. 2018 Jul;108(7):914-923. doi: 10.2105/AJPH.2018.304401.

26.

Noncigarette Tobacco Products-Gateway or Diversion?-Reply.

Watkins SL, Glantz SA, Chaffee BW.

JAMA Pediatr. 2018 Aug 1;172(8):784-785. doi: 10.1001/jamapediatrics.2018.1076. No abstract available.

PMID:
29868756
27.

Tobacco Industry Promotional Strategies Targeting American Indians/Alaska Natives and Exploiting Tribal Sovereignty.

Lempert LK, Glantz SA.

Nicotine Tob Res. 2019 Jun 21;21(7):940-948. doi: 10.1093/ntr/nty048.

28.

Local Movement to Ban Menthol Tobacco Products as a Result of Federal Inaction.

Glantz SA, Gardiner P.

JAMA Intern Med. 2018 May 1;178(5):711-713. doi: 10.1001/jamainternmed.2018.0053. No abstract available.

PMID:
29507930
29.

Electronic Cigarette Use and Progression From Experimentation to Established Smoking.

Chaffee BW, Watkins SL, Glantz SA.

Pediatrics. 2018 Apr;141(4). pii: e20173594. doi: 10.1542/peds.2017-3594. Epub 2018 Mar 5. Erratum in: Pediatrics. 2018 Sep;142(3):.

30.

Effects of Large Cigarette Warning Labels on Smokers' Expected Longevity.

Popova L, Thrul J, Glantz SA.

Am J Health Behav. 2018 Mar 1;42(2):85-92. doi: 10.5993/AJHB.42.2.8.

31.

E-cigarettes Associated With Depressed Smoking Cessation: A Cross-sectional Study of 28 European Union Countries.

Kulik MC, Lisha NE, Glantz SA.

Am J Prev Med. 2018 Apr;54(4):603-609. doi: 10.1016/j.amepre.2017.12.017. Epub 2018 Feb 12.

32.

Regulating Cannabis Manufacturing: Applying Public Health Best Practices from Tobacco Control.

Orenstein DG, Glantz SA.

J Psychoactive Drugs. 2018 Jan-Mar;50(1):19-32. doi: 10.1080/02791072.2017.1422816. Epub 2018 Feb 13.

33.

Impact of E-Cigarette Minimum Legal Sale Age Laws on Current Cigarette Smoking.

Dutra LM, Glantz SA, Arrazola RA, King BA.

J Adolesc Health. 2018 May;62(5):532-538. doi: 10.1016/j.jadohealth.2017.11.302. Epub 2018 Feb 3. Erratum in: J Adolesc Health. 2018 Oct;63(4):517.

34.

Thirty-day smoking in adolescence is a strong predictor of smoking in young adulthood.

Dutra LM, Glantz SA.

Prev Med. 2018 Apr;109:17-21. doi: 10.1016/j.ypmed.2018.01.014. Epub 2018 Feb 3.

35.

E-Cigarettes: Use, Effects on Smoking, Risks, and Policy Implications.

Glantz SA, Bareham DW.

Annu Rev Public Health. 2018 Apr 1;39:215-235. doi: 10.1146/annurev-publhealth-040617-013757. Epub 2018 Jan 11.

36.

The Challenges of Monitoring Illicit Trade Should Not Obscure the Success of Tobacco Tax Policy.

Bialous SA, Glantz SA.

Am J Public Health. 2018 Feb;108(2):161-163. doi: 10.2105/AJPH.2017.304233. No abstract available.

37.
38.

Tobacco industry attempts to frame smoking as a 'disability' under the 1990 Americans with Disabilities Act.

van der Eijk Y, Glantz SA.

PLoS One. 2017 Nov 27;12(11):e0188188. doi: 10.1371/journal.pone.0188188. eCollection 2017.

39.

Sugar industry sponsorship of germ-free rodent studies linking sucrose to hyperlipidemia and cancer: An historical analysis of internal documents.

Kearns CE, Apollonio D, Glantz SA.

PLoS Biol. 2017 Nov 21;15(11):e2003460. doi: 10.1371/journal.pbio.2003460. eCollection 2017 Nov.

40.

Marijuana, Secondhand Smoke, and Social Acceptability.

Glantz SA, Halpern-Felsher B, Springer ML.

JAMA Intern Med. 2018 Jan 1;178(1):13-14. doi: 10.1001/jamainternmed.2017.5301. No abstract available.

41.

Tobacco papers and tobacco industry ties in regulatory toxicology and pharmacology.

Velicer C, St Helen G, Glantz SA.

J Public Health Policy. 2018 Feb;39(1):34-48. doi: 10.1057/s41271-017-0096-6. Epub 2017 Nov 7.

42.

Relationship between spending on electronic cigarettes, 30-day use, and disease symptoms among current adult cigarette smokers in the U.S.

Yao T, Max W, Sung HY, Glantz SA, Goldberg RL, Wang JB, Wang Y, Lightwood J, Cataldo J.

PLoS One. 2017 Nov 7;12(11):e0187399. doi: 10.1371/journal.pone.0187399. eCollection 2017.

43.

United Nations Global Compact: an 'Inroad' into the UN and reputation boost for the tobacco industry.

van der Eijk Y, McDaniel PA, Glantz SA, Bialous SA.

Tob Control. 2018 Jul;27(e1):e66-e69. doi: 10.1136/tobaccocontrol-2017-054055. Epub 2017 Nov 2.

44.

Differences in Adolescent E-cigarette and Cigarette Prevalence in Two Policy Environments: South Korea and the United States.

Cho HJ, Dutra LM, Glantz SA.

Nicotine Tob Res. 2018 Jul 9;20(8):949-953. doi: 10.1093/ntr/ntx198.

45.

Softening Among U.S. Smokers With Psychological Distress: More Quit Attempts and Lower Consumption as Smoking Drops.

Kulik MC, Glantz SA.

Am J Prev Med. 2017 Dec;53(6):810-817. doi: 10.1016/j.amepre.2017.08.004. Epub 2017 Oct 10.

46.

Tobacco Industry Research on Nicotine Replacement Therapy: "If Anyone Is Going to Take Away Our Business It Should Be Us".

Apollonio D, Glantz SA.

Am J Public Health. 2017 Oct;107(10):1636-1642. doi: 10.2105/AJPH.2017.303935. Epub 2017 Aug 17.

47.

Tobacco control law implementation in a middle-income country: Transnational tobacco control network overcoming tobacco industry opposition in Colombia.

Uang R, Crosbie E, Glantz SA.

Glob Public Health. 2018 Aug;13(8):1050-1064. doi: 10.1080/17441692.2017.1357188. Epub 2017 Aug 17.

PMID:
28816610
48.

Mentoring for Success in Tobacco Regulatory Science: A Qualitative Study.

Russo AR, Solis AC, Villanti AC, Wipfli HL, Kern TT, Lawley RK, Collins LK, Abudayyeh HS, Chansky MC, Glantz SA, Samet JM, Benjamin EJ.

Tob Regul Sci. 2017 Jul;3(3):280-292. doi: 10.18001/TRS.3.3.4.

49.

Tobacco Use in Top-Grossing Movies - United States, 2010-2016.

Tynan MA, Polansky JR, Titus K, Atayeva R, Glantz SA.

MMWR Morb Mortal Wkly Rep. 2017 Jul 7;66(26):681-686. doi: 10.15585/mmwr.mm6626a1. Erratum in: MMWR Morb Mortal Wkly Rep. 2017 Oct 06;66(39):1059.

50.

Here Comes Trouble: A Career as a Tobacco Control Activist.

Glantz SA, Rutherford JD.

Circulation. 2017 Jun 6;135(23):2214-2217. doi: 10.1161/CIRCULATIONAHA.117.029134.

PMID:
28584028

Supplemental Content

Loading ...
Support Center